Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study

Stopped Low recruitment, We did not find participants with the M184V mutation , inclusion criteria , throughout 230 resistance tests carried out

Conditions

• HIV-1 Infection

Interventions

• DRUG: Dolutegravir plus lamivudine

Sponsor

Pedro Cahn

Collaborators

• [object Object]